Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis.

Authors:

Hajar Shokri Afra Nasrin Amiri-Dashatan Fatemeh Ghorbani Iradj Maleki Mostafa Rezaei-Tavirani

Gastroenterol Hepatol Bed Bench 2020 ;13(4):292-304

Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Aim: The current study aimed to report a pooled analysis of the association of the circulating levels of liver enzymes and total bilirubin with severe and non-severe COVID-19.

Background: The ongoing coronavirus outbreak is an important threat to health worldwide. Epidemiological data representing greater risk of liver failure in patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).

Methods: Electronic databases were comprehensively searched using Medline, ISI Web of Science, EMBASE, and the Cochrane Library up to July 2020. Outcomes from each relevant study were pooled using a random-effects model. Heterogeneity was analyzed by Q test and I statistics. Sensitivity analysis was also evaluated.

Results: A total of 24 studies were included (4,246 patients) in this study. We found a significant association of COVID-19 severity with increased levels of ALT [SMD: 1.40 U/L; 95% CI (0.93, 1.88); < 0.05, I = 96.5%, 0.000 ], AST [SMD: 2.11 U/L; 95% CI (1.40, 2.83); < 0.05, I = 97.9%, 0.000], LDH [SMD: 3.88 U/L; 95% CI (2.70, 5); < 0.05, I = 98.7%, 0.000] and TBil [SMD: 1.08 mol/L; 95% CI (0.44, 1.72); = 0.001, I = 97.7, 0.000], whereas, ALP values [SMD: 0.31; 95% CI (-1.57, 2.20); = 0.74] was not significant between severe and non-severe COVID-19 patients. Moreover, elevated liver enzymes were found more in males [OR: 1.52, (95% CI 1.26, 1.83), < 0.05] with severe COVID-19 infection than in females.

Conclusion: The alterations of liver function indexes caused by SARS-CoV-2 infection suggested a potential prognosis biomarker for screening of severe patients at early stages of the disease.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682972	PMC

January 2020

Publication Analysis

Top Keywords

Similar Publications

Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis.

Authors:

Yuzhao Dai He He Sheyu Li Lidan Yang Xia Wang Zhi Liu Zhenmei An

Front Endocrinol (Lausanne) 2020 16;11:622589. Epub 2021 Feb 16.

Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.

Aims: Metabolic associated fatty liver disease (MAFLD) is the most common cause of chronic liver disease and is a major health and economic burden in society. New drugs are urgently needed to treat MAFLD. This systematic review and meta-analysis was conducted to evaluate the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with MAFLD. Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.

Authors:

Paulina Vidal-Cevallos Fatima Higuera-De-La-Tijera Norberto C Chávez-Tapia Francisco Sanchez-Giron Eira Cerda-Reyes Victor Hugo Rosales-Salyano Alfredo Servin-Caamaño Martín Uriel Vázquez-Medina Nahum Méndez-Sánchez

Ann Hepatol 2021 Feb 26;24:100338. Epub 2021 Feb 26.

Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation. Puente de Piedra 150, col. Toriello Guerra, C.P. 14050, Mexico City, Mexico. Electronic address:

Introduction And Objectives: As of January 2021, over 88 million people have been infected with COVID-19. Almost two million people have died of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high SOFA score and a D-Dimer >1 µg/mL identifies patients with high risk of mortality. Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical).

Authors:

Flavio A Cadegiani John McCoy Carlos Gustavo Wambier Andy Goren

Cureus 2021 Feb 1;13(2):e13047. Epub 2021 Feb 1.

Dermatology, Applied Biology Inc, Irvine, USA.

Background and objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry and subsequent infectivity are mediated by androgens and the androgen receptors through the regulation of transmembrane protease, serine 2 (TMPRSS2). Androgenetic alopecia (AGA) predisposes males to severe coronavirus disease 2019 (COVID-19) disease, while the use of 5-alpha-reductase inhibitors (5ARis) and androgen receptor antagonists reduce COVID-19 disease severity. In this study, we aimed to determine the potential benefit of dutasteride, a commonly used broad and potent 5ARi, as a treatment for COVID-19. Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance.

Authors:

Yauhen Statsenko Fatmah Al Zahmi Tetiana Habuza Klaus Neidl-Van Gorkom Nazar Zaki

BMJ Open 2021 02 26;11(2):e044500. Epub 2021 Feb 26.

Computer Science, College of Information Technology, United Arab Emirates University, Al Ain, UAE.

Background: Despite the necessity, there is no reliable biomarker to predict disease severity and prognosis of patients with COVID-19. The currently published prediction models are not fully applicable to clinical use.

Objectives: To identify predictive biomarkers of COVID-19 severity and to justify their threshold values for the stratification of the risk of deterioration that would require transferring to the intensive care unit (ICU). Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Postoperative elevation of C-reactive protein levels and high drainage fluid amylase output are strong predictors of pancreatic fistulas after distal pancreatectomy.

Authors:

Katsunori Sakamoto Kohei Ogawa Kei Tamura Miku Iwata Takashi Matsui Yusuke Nishi Tomoyuki Nagaoka Naotake Funamizu Akihiro Takai Yasutsugu Takada

J Hepatobiliary Pancreat Sci 2021 Feb 26. Epub 2021 Feb 26.

Department of Hepato-Biliary-Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Background: The aim of the present study was to identify the predictors of postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP).

Methods: The records of 97 consecutive patients who underwent DP at Ehime University Hospital between June 2009 and August 2020 were retrospectively reviewed. Patients' characteristics, preoperative blood biochemistry data, operative findings, and postoperative findings until postoperative day (POD) 3 were investigated as potential predictors of clinically relevant POPF (CR-POPF). Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Search Our Scientific Publications & Authors